Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA host gene 30 (SNHG30) encodes a long non-coding RNA molecule that serves as the host for small nucleolar RNAs within its intronic regions. These snoRNAs are processed from the primary transcript and participate in modifications of ribosomal RNA and gene expression regulation. SNHG family lncRNAs are implicated in multiple processes including cancer progression, epithelial-mesenchymal transition, cell proliferation, and apoptosis, primarily via their derivative snoRNAs and through regulatory gene interaction. However, SNHG30's specific biological and clinical roles remain to be comprehensively characterized, although by analogy to other SNHGs, dysregulation may contribute to cancer and cell growth via RNA-mediated regulatory mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA host gene 30 (SNHG30).